Rhinorrhea, cough and fatigue in patients taking sitagliptin

Sitagliptin is a dipeptidyl peptidase-4 (DPP IV, CD26) inhibitor indicated for treatment of Type II diabetes as a second line therapy after metformin. We report fifteen sitagliptin intolerant patients who developed anterior and posterior rhinorrhea, cough, dyspnea, and fatigue. Symptoms typically de...

Descripción completa

Detalles Bibliográficos
Autores principales: Baraniuk, James N, Jamieson, Mary J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877018/
https://www.ncbi.nlm.nih.gov/pubmed/20462426
http://dx.doi.org/10.1186/1710-1492-6-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877018/
https://www.ncbi.nlm.nih.gov/pubmed/20462426
http://dx.doi.org/10.1186/1710-1492-6-8

Ejemplares similares